Total Payments
$13,937
2024 Payments
$2,328
Companies
2
Transactions
77
Medicare Patients
1,638
Medicare Billing
$224,081
Payment Breakdown by Category
Other$12,925 (92.7%)
Food & Beverage$1,012 (7.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,925 | 7 | 92.7% |
| Food and Beverage | $1,012 | 70 | 7.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $13,911 | 76 | $0 (2024) |
| ABBVIE INC. | $25.06 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,328 | 10 | Novo Nordisk Inc ($2,302) |
| 2023 | $8,620 | 28 | Novo Nordisk Inc ($8,620) |
| 2022 | $2,864 | 38 | Novo Nordisk Inc ($2,864) |
| 2021 | $125.00 | 1 | Novo Nordisk Inc ($125.00) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.27 | General |
| Category: Obesity | ||||||
| 07/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $159.50 | General |
| Category: Obesity | ||||||
| 06/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: Obesity | ||||||
| 06/22/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,073.50 | General |
| Category: Obesity | ||||||
| 05/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: Obesity | ||||||
| 04/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.48 | General |
| Category: Obesity | ||||||
| 03/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: Obesity | ||||||
| 02/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Obesity | ||||||
| 01/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: Obesity | ||||||
| 11/10/2023 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,656.25 | General |
| Category: Obesity | ||||||
| 11/10/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $68.64 | General |
| Category: Obesity | ||||||
| 11/01/2023 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Obesity | ||||||
| 10/25/2023 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Obesity | ||||||
| 10/12/2023 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,642.85 | General |
| Category: Obesity | ||||||
| 09/26/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Obesity | ||||||
| 08/08/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Obesity | ||||||
| 07/25/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.32 | General |
| Category: Obesity | ||||||
| 07/10/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Obesity | ||||||
| 06/16/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Obesity | ||||||
| 05/30/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Obesity | ||||||
| 05/25/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $8.72 | General |
| Category: Obesity | ||||||
| 05/25/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $2.69 | General |
| Category: Obesity | ||||||
| 05/16/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: Obesity | ||||||
| 04/27/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.83 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 320 | 429 | $85,424 | $39,850 |
| 2022 | 7 | 397 | 534 | $116,034 | $50,053 |
| 2021 | 6 | 396 | 547 | $128,138 | $56,112 |
| 2020 | 7 | 525 | 767 | $174,112 | $78,067 |
Total Patients
1,638
Total Services
2,277
Medicare Billing
$224,081
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 109 | 128 | $35,584 | $15,225 | 42.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 94 | 163 | $28,036 | $13,580 | 48.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 117 | 138 | $21,804 | $11,045 | 50.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 92 | 185 | $31,820 | $13,663 | 42.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 70 | 77 | $21,406 | $10,808 | 50.5% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 65 | 71 | $19,596 | $9,264 | 47.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 83 | 93 | $14,694 | $7,185 | 48.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 16 | 29 | $18,096 | $4,620 | 25.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 56 | 61 | $7,686 | $3,204 | 41.7% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 15 | 18 | $2,736 | $1,307 | 47.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 94 | 194 | $33,368 | $15,563 | 46.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 85 | 94 | $26,132 | $13,382 | 51.2% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 60 | 65 | $17,940 | $8,463 | 47.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 17 | 47 | $29,328 | $8,396 | 28.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 84 | 89 | $14,062 | $7,126 | 50.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 56 | 58 | $7,308 | $3,181 | 43.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 103 | 242 | $41,624 | $19,744 | 47.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 105 | 114 | $31,692 | $17,219 | 54.3% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 78 | 94 | $25,944 | $12,889 | 49.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 21 | 63 | $39,312 | $11,081 | 28.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 109 | 120 | $18,960 | $9,904 | 52.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 89 | 96 | $12,096 | $5,233 | 43.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 20 | 38 | $4,484 | $1,996 | 44.5% |
About Dr. Jamie Caudill, M.D
Dr. Jamie Caudill, M.D is a Pediatrics healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2010. The National Provider Identifier (NPI) number assigned to this provider is 1699095182.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jamie Caudill, M.D has received a total of $13,937 in payments from pharmaceutical and medical device companies, with $2,328 received in 2024. These payments were reported across 77 transactions from 2 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($12,925).
As a Medicare-enrolled provider, Caudill has provided services to 1,638 Medicare beneficiaries, totaling 2,277 services with total Medicare billing of $224,081. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Mobile, AL
- Active Since 06/07/2010
- Last Updated 05/02/2014
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1699095182
Products in Payments
- Wegovy (Drug) $11,048
- Saxenda (Drug) $2,864
- DALVANCE (Drug) $25.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Mobile
Dr. Druhan Howell, M.d, M.D
Pediatrics — Payments: $155,457
Pediatrics $155,457
Dr. James Wiley, M.d, M.D
Pediatrics — Payments: $69,924
Pediatrics $69,924
Anne-Marie Kaulfers, M.d, M.D
Pediatrics — Payments: $22,957
Pediatrics $22,957
David Gremse, M.d, M.D
Pediatrics — Payments: $11,157
Pediatrics $11,157
Sonia Savani, M.d, M.D
Pediatrics — Payments: $7,248
Pediatrics $7,248
Hilary Seay, Np, NP
Pediatrics — Payments: $4,450
Pediatrics $4,450